Peter Noyce
- Geriatrics and Gerontology top 0.1%
- Pharmaceutical Practices and Patient Outcomes 59
- Family Practice top 0.2%
- Toxicology top 0.5%
- General Health Professions top 0.5%
- Primary Care and Health Outcomes 29
-
- Health Systems, Economic Evaluations, Quality of Life 18
- Healthcare Policy and Management 15
- Pharmaceutical Economics and Policy 15
-
- Pharmaceutical industry and healthcare 16
-
- Healthcare Quality and Management 16
-
- Innovations in Medical Education 11
- Co-authors
- Darren M. AshcroftJ A CantrillKaren HassellNicola J. GrayChuenjid KongkaewJonathan D. KleinEllen SchafheutleTracy S. Sesselberg
- Journals
- International Journal of Pharmacy Practice (25 papers)Research in Social and Administrative Pharmacy (12 papers)Journal of Health Services Research & Policy (5 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Peter Noyce
132 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Geriatrics and Gerontology 1.6k
- Family Practice 529
- Applied Microbiology and Biotechnology 181
- Toxicology 275
- General Health Professions 1.8k
Countries citing papers authored by Peter Noyce
This map shows the geographic impact of Peter Noyce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Noyce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Noyce more than expected).
Fields of papers citing papers by Peter Noyce
This network shows the impact of papers produced by Peter Noyce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Noyce. The network helps show where Peter Noyce may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Noyce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 14 | |
| 2 | 2014 | 2 | |
| 3 | Managing long-term conditions in the community - scope for self-care | 2012 | 2 |
| 4 | What key components are required to improve pharmacist-GP collaboration? | 2012 | 1 |
| 5 | What could the NHS appraisal system contribute to revalidation in pharmacy | 2011 | 3 |
| 6 | 2011 | 1 | |
| 7 | What factors should you focus on to provide meaningful risk assessments | 2010 | 1 |
| 8 | Prescription charges - Are policy makers in tune with public opinion? | 2008 | 0 |
| 9 | Commissioning services and the new community pharmacy contract: (4) Governance and performance management | 2006 | 4 |
| 10 | Commissioning services and the new community pharmacy contract: (1)Pharmaceutical needs assessments and uptake of new pharmacy contracts | 2006 | 8 |
| 11 | Commissioning services and the new community pharmacy contract: (2) Drivers, barriers and approaches to commissioning | 2006 | 8 |
| 12 | Commissioning services and the new community pharmacy contract: (3) Uptake of enhanced services | 2006 | 14 |
| 13 | Setting up local pharmaceutical services: lessons for primary care trusts | 2005 | 1 |
| 14 | Research governance and pharmacy practice research: A case-study | 2005 | 0 |
| 15 | Setting up local pharmaceutical services - lessons for pharmacy contractors | 2005 | 4 |
| 16 | Role and uptake of local pharmaceutical services contracts in commissioning community pharmacy services | 2005 | 3 |
| 17 | Reporting, reflecting on and learning from adverse events in community pharmacy: development and evaluation of an incident reporting form | 2005 | 3 |
| 18 | Can the Royal Pharmaceutical Society be a regulator as well as a modern, professional, learned body? | 2002 | 2 |
| 19 | The complexities of skill mix in community pharmacy | 2002 | 10 |
| 20 | A Partnership between community pharmacists and general practitioners in the management of ischaemic heart disease: a feasibility study | 2001 | 3 |
About Peter Noyce
Peter Noyce is a scholar working on Geriatrics and Gerontology, Family Practice, Medical Terminology, Health Information Management and General Health Professions, having authored 140 papers that have together received 4.5k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (59 papers), Primary Care and Health Outcomes (29 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers), Pharmaceutical industry and healthcare (16 papers), Healthcare Quality and Management (16 papers), Healthcare Policy and Management (15 papers), Pharmaceutical Economics and Policy (15 papers) and Innovations in Medical Education (11 papers). The work is most often cited by research in Geriatrics and Gerontology (1.6k citations), Family Practice (529 citations), Applied Microbiology and Biotechnology (181 citations), Toxicology (275 citations) and General Health Professions (1.8k citations). Peter Noyce has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Darren M. Ashcroft, J A Cantrill, Karen Hassell, Nicola J. Gray, Chuenjid Kongkaew, Jonathan D. Klein, Ellen Schafheutle, Tracy S. Sesselberg, Paul Bissell and Paul Ward. Their work appears in journals such as International Journal of Pharmacy Practice, Research in Social and Administrative Pharmacy, Journal of Health Services Research & Policy, Health Policy and Health & Social Care in the Community.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.